30 June 2026
As a proudly independent HealthScience communications consultancy, Oxford PharmaGenesis has worked tirelessly to earn deep client trust, growing through repeat business and personal recommendation in medical affairs and market access.
We were busy at last month’s European Medical Writers Association Conference in Birmingham, UK. Chris Winchester, our Managing Director, led an Expert Seminar Series workshop, a Joint Position Statement launch seminar and presented a poster.
Oxford PharmaGenesis joined this year’s International Society for Medical Publication Professionals (ISMPP) Annual Meeting, which attracted more than 550 publication professionals from the pharmaceutical industry, medical communications agencies and publishers.
Oxford PharmaGenesis has been named as one of the ‘1000 Companies to Inspire Britain’ in a report published this week by the London Stock Exchange Group.
At the April MedComms Brunch Club in Oxford, expert insights into the latest trends and industry updates were presented by Dr Chris Winchester, our Managing Director, Dr Paul Farrow, Communications Director, and Saundra Hemmings, Project Manager.
Oxford PharmaGenesis Commercial Director Dr Richard White was Chairman of the 16th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, USA on 21–22 February 2017, and provides his insights on the conference.
Teams across the Oxford PharmaGenesis offices have been celebrating Pi Day after more than 100 of us registered with ORCID, joining a community of over 3.14 million people who share the vision of transparency and trust in research and innovation.
